Disperazol, a spin out from the Costerton Biofilm Center at the University of Copenhagen, is developing compounds that dismantle Gram-negative biofilms.
Disperazol Pharma is a member of the INCATE Cohort and a Member of the BEAM Alliance.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Copenhagen, Dk
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.disperazolpharma.com
- HQ
- Copenhagen
Disperazol Pharma Aps Questions
Disperazol Pharma Aps's website is http://www.disperazolpharma.com
Disperazol Pharma Aps's LinkedIn profile is https://dk.linkedin.com/company/disperazol-pharma
Disperazol Pharma Aps has
1 employees.
View email and phone details for 1
employees at Disperazol Pharma Aps.
Disperazol Pharma Aps's industry is
Biotechnology Research
Disperazol Pharma Aps's top competitors are
Granzer Regulatory Consulting & Services Gmbh,
Omnicin Therapeutics,
Enterotarget,
Cultured Therapeutics,
Lumento Therapeutics,
Degar Consulting,
Arivin Therapeutics,
Aevisbio, Inc,
Intubio,
Qbiom.
Disperazol Pharma Aps's categories are Biotechnology Research
Disperazol Pharma Aps's founding year is 2023
